Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
8.36
-0.15 (-1.76%)
At close: Oct 17, 2025, 4:00 PM EDT
8.37
+0.01 (0.12%)
After-hours: Oct 17, 2025, 4:31 PM EDT
Inogen Revenue
Inogen had revenue of $92.28M in the quarter ending June 30, 2025, with 3.96% growth. This brings the company's revenue in the last twelve months to $343.47M, up 5.15% year-over-year. In the year 2024, Inogen had annual revenue of $335.71M with 6.35% growth.
Revenue (ttm)
$343.47M
Revenue Growth
+5.15%
P/S Ratio
0.61
Revenue / Employee
$448,397
Employees
766
Market Cap
226.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
INGN News
- 4 days ago - Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025 - Business Wire
- 23 days ago - Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer - Business Wire
- 2 months ago - Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Inogen Announces Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 4 months ago - Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy - Business Wire
- 5 months ago - Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough - Benzinga
- 5 months ago - Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript - Seeking Alpha